BACKGROUND: The existing approaches to the treatment of the atrophic maxilla are difficult and involve an element of risk. PURPOSE: The aim of the present study was to establish a new surgical/prosthetic protocol for the treatment of extremely atrophic maxillae using four zygomatic implants (ZIs) in an immediate loading system. MATERIALS AND METHODS: Twelve patients were treated with the surgical placement of 48 ZIs, and the totally edentulous maxillae were rehabilitated with protocol-type maxillary prostheses rigidly fixed to the ZIs in an immediate loading system. Follow-up was conducted at 6 months and again at 30 months. RESULTS: Of the 48 ZIs inserted, one implant failed to achieve osseointegration. The prosthetic components fitted well and no sinus pathology was detected in any of the patients. CONCLUSION: The surgical/prosthetic protocol showed that it was possible to insert four ZIs in an immediate loading system and achieve stability for up to 30 months.
BACKGROUND: The existing approaches to the treatment of the atrophic maxilla are difficult and involve an element of risk. PURPOSE: The aim of the present study was to establish a new surgical/prosthetic protocol for the treatment of extremely atrophic maxillae using four zygomatic implants (ZIs) in an immediate loading system. MATERIALS AND METHODS: Twelve patients were treated with the surgical placement of 48 ZIs, and the totally edentulous maxillae were rehabilitated with protocol-type maxillary prostheses rigidly fixed to the ZIs in an immediate loading system. Follow-up was conducted at 6 months and again at 30 months. RESULTS: Of the 48 ZIs inserted, one implant failed to achieve osseointegration. The prosthetic components fitted well and no sinus pathology was detected in any of the patients. CONCLUSION: The surgical/prosthetic protocol showed that it was possible to insert four ZIs in an immediate loading system and achieve stability for up to 30 months.
Authors: Mark Krauthammer; Amir Shuster; Daphna Mezad-Koursh; Benjamin Shlomi; Chaim Stolovitch; Igal Leibovitch Journal: Am J Ophthalmol Case Rep Date: 2016-11-17